18 results match your criteria: "Dr. Abdurrahman Yurtaslan Training and Research Hospital[Affiliation]"
Heliyon
October 2024
Ankara University Medical Faculty, Department of Medical Oncology, Turkey.
J Bone Oncol
August 2024
Department of Pediatric Hematology-Oncology, Dr. Abdurrahman Yurtaslan Training and Research Hospital, Ankara, Turkey.
Objectives: The present study evaluates the clinical outcomes of children, adolescents and adults with Ewing sarcoma and identifies the prognostic factors.
Methods: Included in the study were 222 pediatric and adult patients diagnosed with Ewing sarcoma (EwS) who were followed up between 1992 and 2019, and whose data were analyzed retrospectively.
Results: The median age of 131 male and 91 female patients included in the study was 13 (1-64).
Support Care Cancer
May 2024
Department of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Turkey.
Objective: To evaluate the effects of complete decongestive therapy (CDT) on cancer-related fatigue, sleep quality, and lymphedema-specific quality of life using validated and reliable questionnaires in cancer patients being commendable.
Material And Methods: This prospective study includes 94 patients who had postmastectomy lymphedema syndrome. The demographic characteristics of the patients were recorded.
Biomol Biomed
March 2024
Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
This study addresses the gap in understanding the prognostic relevance of hypoxia-inducible factor-1 alpha (HIF-1 alpha) expression in metastatic cervical squamous cell carcinoma (SCC) patients undergoing anti-vascular endothelial growth factor (VEGF)-based therapy. A retrospective multicenter study (n = 34) explored HIF-1 alpha expression via immunohistochemistry in patients treated with platinum chemotherapy and bevacizumab. Median progression-free survival (PFS) was significantly lower in the HIF-1 alpha low score group compared to the high score group (4.
View Article and Find Full Text PDFAm J Clin Oncol
December 2023
Departments of Medical Oncology.
Objective: We represent Sprouty 2 (Spry2) expression analysis and its association with key driver mutations and clinical features of patients with non-small cell lung cancer as the largest ex vivo data.
Methods: The strength of Spry2 expression was evaluated using the immunoreactivity score (IRS), which was calculated using the following formula: IRS=(staining intensity score) SI×(percentage of positively stained cells) PP. The median IRS score was defined as the cutoff value.
Mol Imaging Radionucl Ther
February 2023
Dr. Abdurrahman Yurtaslan Training and Research Hospital, Clinic of Medical Oncology, Ankara, Turkey.
Internal herniation may be seen more frequently in patients with intra-abdominal surgery and malignancy history. We presented a 58-year-old male patient diagnosed with rectal adenocarcinoma seven years ago with a history of surgery and pelvic radiotherapy. When the abdominal computed tomography (CT) image was taken during routine oncology follow-up, a lesion mimicking a serosal implant on the anterior abdominal wall was detected.
View Article and Find Full Text PDFInt Urol Nephrol
January 2023
Urology Department, Department of Urology, Ankara Dr. Abdurrahman Yurtaslan Training and Research Hospital, Vatan Street No:91, Yenimahalle, 06200, Ankara, Turkey.
Introduction: Office-based flexible cystoscopy is a common outpatient procedure in daily urology practice. Sometimes, cystoscopy procedures are performed on the initial day or scheduled on the following days. We designed this study to compare immediate versus scheduled cystoscopy in terms of anxiety and pain.
View Article and Find Full Text PDFAm J Ophthalmol Case Rep
March 2022
Ulucanlar Eye Training and Research Hospital, Department of Ophthalmology, Ankara, Turkey.
Purpose: In this paper, we present a case of acute clouding of a trifocal intraocular lens (IOL) that resolved spontaneously by the day after surgery.
Observations: A 68-year-old woman with a nuclear cataract in the right eye was scheduled for cataract surgery with +21.00 diopter trifocal IOL (AT LISA tri 839MP, Carl Zeiss Meditec AG, Germany) implantation.
Arch Med Sci
February 2019
Department of Medical Oncology, Anatolian Health Center, Istanbul, Turkey.
Introduction: We aimed to investigate the efficacy and side effects of bendamustine in relapsed/refractory lymphoma patients in Turkey.
Material And Methods: In this retrospective study, we included relapsed/refractory Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) patients who underwent multiple lines of chemotherapy. The primary endpoint was to determine the objective response and toxicity.
Int J Cardiol
November 2018
Dr. Abdurrahman Yurtaslan Training and Research Hospital, Department of Internal Medicine, Division of Hematology, Ankara, Turkey.
J BUON
August 2019
Dr.Abdurrahman Yurtaslan Training and Research Hospital, Dept of Medical Oncology, Ankara.
Clin Appl Thromb Hemost
September 2018
15 Department of Medical Oncology, Pamukkale University Medical Faculty, Denizli, Turkey.
Low Urin Tract Symptoms
January 2019
Department of Urology, Dr Abdurrahman Yurtaslan Training and Research Hospital, Ankara, Turkey.
Objective: Urodynamic studies (UDS) include assessments of the physics and physiology of the lower urinary tract (LUT). It is an invasive test and patients can feel fear and anxiety, especially at the beginning of the test. The aim of this study was to determine whether listening to music during urodynamic study decreases patient anxiety and pain.
View Article and Find Full Text PDFJ Gastrointest Cancer
June 2016
Department of Internal Medicine, Division of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey.
Background: Gastric cancer is the second most common cause of cancer-related death in the world, and its prognosis remains poor with a median overall survival of 12 months for advanced disease. Advances in the understanding of molecular genetics have led to the development of directed molecular targeted therapy in gastric cancer, leading to improve patient outcomes and quality of life.
Discussion: In the treatment of human epidermal growth factor receptor 2 (HER2)-positive gastric cancer, the addition of trastuzumab significantly improves survival in the first-line setting of therapy.
Thorac Cancer
January 2015
Department of Medical Oncology, Izmir University Faculty of Medicine Izmir, Turkey.
Background: Soft tissue sarcomas (STSs) are rare malignant tumors of embryogenic mesoderm origin. Primary thoracic STSs account for a small percentage of all STSs and limited published information is available. This study aimed to identify the prognostic factors for thoracic STSs and evaluate the disease's clinical outcomes.
View Article and Find Full Text PDFJpn J Clin Oncol
May 2015
Department of Internal Medicine, Division of Medical Oncology, Gazi University Faculty of Medicine, Ankara.
Objective: Determination of human epidermal growth factor receptor-2 status in advanced gastric cancer is important in clinical decision making. In the trastuzumab for GC trial, trastuzumab-based therapy demonstrated a significant overall survival benefit in patients with human epidermal growth factor receptor-2-positive advanced gastric cancer. Human epidermal growth factor receptor-2 discordance in gastric cancer primary and its metastases has been long debated.
View Article and Find Full Text PDFOptom Vis Sci
January 2015
*MD Department of Ophthalmology, Yozgat State Hospital, Yozgat, Turkey (BKY); Department of Ophthalmology (SO, KSC, MCO) and Department of Medical Oncology (UC, SB, MBe), Gazi University School of Medicine, Ankara, Turkey; Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Training and Research Hospital, Ankara, Turkey (UD); and Department of Medical Oncology, Sakarya University Training and Research Hospital, Sakarya, Turkey (MBa).
Purpose: To evaluate the morphological and functional short-term effects of systemic bevacizumab on healthy eyes of cancer patients morphologically and functionally.
Methods: The patients who underwent a chemotherapy regimen because of colon, lung, and breast cancer at the Department of Medical Oncology of the Gazi University School of Medicine between years 2010 and 2012 were included. All patients were administrated intravenous bevacizumab in three different dosages (5, 7.
Breast Care (Basel)
March 2013
Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Gaziantep, Turkey.
Background: The efficacy and safety of the lapatinib and capecitabine combination remain elusive in elderly patients with metastatic breast cancer (MBC), who progress after trastuzumab-based therapy.
Patients And Methods: A total of 26 patients with HER2-positive MBC were included in this retrospective multicenter study. Median age was 69 years (range 65-82 years).